O'Reilly EM - Search Results

1

A woman with metastatic pancreatic neuroendocrine tumor.

Shoushtari AN, Covey AM, Zaatari G, Shamseddine A, Epstein AS, Haydar A, Naghy M, Mukherji D, Kelsen DP, Abou-Alfa GK, O'Reilly EM. Shoushtari AN, et al. Gastrointest Cancer Res. 2014 Jan;7(1):27-32. Gastrointest Cancer Res. 2014. PMID: 24558512 Free PMC article. No abstract available.

2

Irinotecan and cisplatin in upper gastrointestinal malignancies.

Enzinger PC, Ilson DH, Saltz LB, O'Reilly EM, Kelsen DP. Enzinger PC, et al. Oncology (Williston Park). 1998 Aug;12(8 Suppl 6):110-3. Oncology (Williston Park). 1998. PMID: 9726102 Review.

3

A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma.

O'Reilly EM, Ilson DH, Saltz LB, Heelan R, Martin L, Kelsen DP. O'Reilly EM, et al. Cancer Invest. 1999;17(3):195-200. doi: 10.3109/07357909909021421. Cancer Invest. 1999. PMID: 10099658 Clinical Trial.

4

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer.

Ilson DH, Saltz L, Enzinger P, Huang Y, Kornblith A, Gollub M, O'Reilly E, Schwartz G, DeGroff J, Gonzalez G, Kelsen DP. Ilson DH, et al. J Clin Oncol. 1999 Oct;17(10):3270-5. doi: 10.1200/JCO.1999.17.10.3270. J Clin Oncol. 1999. PMID: 10506629 Clinical Trial.

5

5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma.

Fata F, Ron IG, Kemeny N, O'Reilly E, Klimstra D, Kelsen DP. Fata F, et al. Cancer. 1999 Oct 1;86(7):1129-34. doi: 10.1002/(sici)1097-0142(19991001)86:7<1129::aid-cncr5>3.0.co;2-4. Cancer. 1999. PMID: 10506695

6

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.

Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK, Casper ES. Fata F, et al. Cancer. 1999 Nov 15;86(10):2034-7. Cancer. 1999. PMID: 10570428 Clinical Trial.

7

A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.

O'Reilly EM, Stuart KE, Sanz-Altamira PM, Schwartz GK, Steger CM, Raeburn L, Kemeny NE, Kelsen DP, Saltz LB. O'Reilly EM, et al. Cancer. 2001 Jan 1;91(1):101-5. doi: 10.1002/1097-0142(20010101)91:1<101::aid-cncr13>3.0.co;2-k. Cancer. 2001. PMID: 11148565 Clinical Trial.

8

Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.

Sharma S, Kemeny N, Schwartz GK, Kelsen D, O'Reilly E, Ilson D, Coyle J, De Jager RL, Ducharme MP, Kleban S, Hollywood E, Saltz LB. Sharma S, et al. Clin Cancer Res. 2001 Dec;7(12):3963-70. Clin Cancer Res. 2001. PMID: 11751488 Clinical Trial.

9

Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer.

Culliford AT 4th, Brooks AD, Sharma S, Saltz LB, Schwartz GK, O'Reilly EM, Ilson DH, Kemeny NE, Kelsen DP, Guillem JG, Wong WD, Cohen AM, Paty PB. Culliford AT 4th, et al. Ann Surg Oncol. 2001 Dec;8(10):787-95. doi: 10.1007/s10434-001-0787-9. Ann Surg Oncol. 2001. PMID: 11776492

10

A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan.

Sharma S, Kemeny N, Kelsen DP, Ilson D, O'Reilly E, Zaknoen S, Baum C, Statkevich P, Hollywood E, Zhu Y, Saltz LB. Sharma S, et al. Ann Oncol. 2002 Jul;13(7):1067-71. doi: 10.1093/annonc/mdf173. Ann Oncol. 2002. PMID: 12176785 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

377 results

Search Page